Navigation Links
ThromboGenics N.V. - Business Update
Date:5/13/2008

us.

---------------------------------

(1) Cell, 2 November 2007, ANTI-PlGF INHIBITS GROWTH OF VEGF(R)-INHIBITOR RESISTANT TUMORS WITHOUT AFFECTING HEALTHY VESSELS - Christian Fischer, Bart Jonckx, Massimiliano Mazzone, Serena Zacchigna, Monica Autiero, Emmanuel Chorianopoulos, Marta Koch, Maria Demol, Sabine Wyns, Lucia Pattarini, Nico van Rooijen, Stephane Plaisance, Mauro Giacca, Mieke Dewerchin, Lieve Moons, Jean Marie Stassen, Desire Collen & Peter Carmeliet

For further information please contact:

ThromboGenics:

Prof. Desire Collen, Tel: +32(0)16-34-61-94;

Dr. Patrik De Haes, Fax +32(0)16-34-61-34.

Citigate Dewe Rogerson:

Sylvie Berrebi / Amber Bielecka / David Dible,

Tel: +44(0)207-638-95-71,

Mobile: +44(0)7767-771-533.


'/>"/>
SOURCE ThromboGenics NV
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007
2. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
3. ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402
4. ThromboGenics and BioInvent Announce Publication of Exciting Data on a Novel Class of Angiogenesis Inhibitors in Cell
5. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
6. ThromboGenics Presents Results of the Phase I Trial of TB-402 at the Prestigious American Society of Hematology Annual Meeting
7. ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
8. ThromboGenics Announces 2007 Full Year Results
9. ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
10. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
11. DuPont Leaders Brief Investors on Agriculture Businesses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Korea , May 23, 2013 ... SillaJen, Inc., a private biotherapeutics and contract research ... biological products for cancer, announced today a publication ... patients treated with the oncolytic and immunotherapeutic vaccinia ... This research was published in the May 15 ...
(Date:5/23/2013)... Bed bugs compromised Penn State. A ... it. Meanwhile, My Cleaning Products offered complimentary samples of its ... pests without using harmful chemical elements. , Based on ... affected building was actually a dormitory , My Cleaning ... on May 13 and bed bug presence was confirmed on ...
(Date:5/22/2013)... PA (PRWEB) May 22, 2013 Oven ... with the integrated potentiometers or via a PC ... design measuring two and one half inches square can ... a zero voltage switched, low noise solid state relay. ... power isolation for the communication port and sensor input. ...
(Date:5/22/2013)... The Conference Forum announced the launch ... Trials conference taking place on September 19-20 at the ... Disruptive thinkers from Novartis, Pfizer, Eli Lilly, Shire, Medimmune, ... reduce expensive infrastructure, engage patients and generate credible clinical ... or novel, or it must change the very nature ...
Breaking Biology Technology:Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3Penn State Dorm Infested with Bed Bugs, My Cleaning Products Offers Complimentary Sample of Bed Bug Spray to Help Bed Bug Victims 2New AC Temperature Controller Announced by Oven Industries 2Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2
... , ... Kuantan, Malaysia facility awarded ISO13485 medical manufacturing certification. , ... Weybridge, United Kingdom (PRWEB) January ... today that its manufacturing facility in Kuantan, Malaysia has received ISO 13485:2003 medical ...
... , WASHINGTON , Jan. 22 The Advisory Board ... conference call hosted by Robert W. Musslewhite , Chief Executive Officer ... Company,s financial results for the quarter ended December 31, 2009 . ... at 6:00 p.m., Eastern Time .  The Company plans to release ...
... , , Twenty leading US ... the benefits of NIH funding through the 2009 Recovery and ... In advance of the one-year anniversary of the ... twenty of the nation,s leading research institutions, patient advocates and ...
Cached Biology Technology:All TT Electronics Integrated Manufacturing Services Facilities Accredited with Medical Manufacturing Standard 2The Advisory Board Company Schedules Third Quarter Conference Call for February 4, 2010 2A Recovery Act Success Story: NIH Funding of Biomedical Innovation Is Creating Jobs, Fueling Industry Growth, and Helping Reduce Long-term Health Care Costs 2A Recovery Act Success Story: NIH Funding of Biomedical Innovation Is Creating Jobs, Fueling Industry Growth, and Helping Reduce Long-term Health Care Costs 3
(Date:5/23/2013)... Bochum,s medics have succeeded in treating cerebral palsy with ... brain damage, a 2.5 year old boy had been ... of survival. Just two months after treatment with the ... over the following months, the child learned to speak ... those from a Korean study, dispel the long-held doubts ...
(Date:5/23/2013)... Neuron , the team reveal the interplay of ... funded by the Wellcome Trust and BBSRC. , ... we improve our perceptual abilities. While these changes can ... also affect the fidelity of that response. ... explains: "When you communicate with others, you can make ...
(Date:5/22/2013)... conclude that the 20 percent reduction in lung ... chest X-ray (CXR) screening previously reported in the ... centers in the United States. , Philadelphia, PAPhysicians ... about the benefits and risks of LDCT lung ... New England Journal of Medicine of the ...
Breaking Biology News(10 mins):First successful treatment of pediatric cerebral palsy with autologous cord blood 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 2NLST: CT detects twice as many lung cancers as X-ray at initial screening exam 3
... only to be central to the process that causes ... muting the high from methamphetamine and other addictive drugs. ... cation transporter 3 or oct3, fills a longstanding gap ... symptoms like tremor, stiffness, slowness of movement and postural ...
... Wash. -- Researchers have detected common plant toxins that ... fires. The results from the new study also suggest ... - a reason to keep human exposures to a ... -- known as alkaloids -- helps researchers understand how ...
... scientists from Cornell University have developed a new tool ... the origins of specific gene mutations. This research, published ... ( http://www.genetics.org ), helps shed light on times ... helps scientists close in on gene mutations that make ...
Cached Biology News:Brain protein central to both Parkinson's, drug addiction identified 2Brain protein central to both Parkinson's, drug addiction identified 3Brain protein central to both Parkinson's, drug addiction identified 4Potentially harmful chemicals found in forest fire smoke 2Tiny differences in our genes help shed light on the big picture of human history 2